e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Pulmonary embolism: from diagnosis to prognosis and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
COPD is an indipendent risk factor for in-situ pulmonary artery thrombosis
P. Intiglietta (bari, Italy), M. Peragine (Acquaviva delle Fonti, Italy), P. Buonamico (bari, Italy), G. Castellana (Cassano delle Murge, Italy), O. Resta (bari, Italy)
Source:
International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Session:
Pulmonary embolism: from diagnosis to prognosis and treatment
Session type:
Poster Discussion
Number:
3649
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Intiglietta (bari, Italy), M. Peragine (Acquaviva delle Fonti, Italy), P. Buonamico (bari, Italy), G. Castellana (Cassano delle Murge, Italy), O. Resta (bari, Italy). COPD is an indipendent risk factor for in-situ pulmonary artery thrombosis. 3649
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Factors predicting pulmonary artery pressure after acute pulmonary thromboembolism
Source: Eur Respir J 2001; 18: Suppl. 33, 380s
Year: 2001
Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005
Is intracardiac thrombus a risk factor for the development of pulmonary artery aneurysm in behcet disease?
Source: Eur Respir J 2002; 20: Suppl. 38, 63s
Year: 2002
Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012
Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Risk of deep vein thrombosis and pulmonary embolism in asthma
Source: Eur Respir J 2013; 42: 655-661
Year: 2013
Chronic thromboembolic pulmonary hypertension in acute pulmonary embolism: A risk factor evaluation study
Source: Virtual Congress 2020 – Pulmonary embolism
Year: 2020
Prediction of outcome after PEA in chronic thromboembolic pulmonary hypertension using indexed pulmonary artery diameter
Source: Eur Respir J 2014; 43: 909-912
Year: 2014
Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Fatal dissection of the pulmonary artery in pulmonary arterial hypertension
Source: Eur Respir Rev 2009; 18: 181-185
Year: 2009
The development of pulmonary hypertension after first episode of acute pulmonary embolism and related risk factors
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Venous thromboemboli and exacerbations of COPD
Source: Eur Respir J 2010; 35: 1243-1248
Year: 2010
Chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Update on venous thromboembolism
Year: 2007
Chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2004; 23: 637-648
Year: 2004
Fibrinogen AaThr312Ala polymorphism predisposes to chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2007 - Acute and chronic pulmonary embolism
Year: 2007
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
Source: International Congress 2019 – State of the art session: Pulmonary vascular diseases
Year: 2019
Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018
Year: 2019
Clinical presentation and outcome of venous thromboembolism in COPD
Source: Eur Respir J 2012; 39: 862-868
Year: 2012
A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development
Source: Eur Respir J 2003; 22: Suppl. 45, 221s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept